Developer docs
API playgroundTry for free, no card

Search company profiles

UBCare

Full company profile

uuid000frb7

Namestring
UBCare
Legal namestring
(주)GC메디아이
Websiteurl
ubcare.co.kr
Company typeenum
Private
Founded yearint
1992
Descriptiontext

UBCare, operating commercially as GC MediAI (주)GC메디아이), is a South Korean medical AI and healthcare IT company founded in 1992 and headquartered in Seoul's Seongdong-gu district. The company operates a platform-plus-modules architecture branded 'Medical OS' that connects hospitals, clinics, pharmacies, pharmaceutical manufacturers, and patients through four business segments: Medical Infrastructure (its market-leading 의사랑 EMR and 유팜 pharmacy management system, plus the 오토팩 pharmacy automation solution), Data & Marketing (prescription-data analytics for pharma/biotech, including the newly launched UBIST OTC general medication market analysis solution), Platform (patient-facing appointment booking and chronic disease management connected to EMR), and Distribution & Medical Devices (an integrated online-offline pharma and device distribution network).

The underlying technology combines proprietary EMR and pharmacy management software with prescription data aggregation across both outpatient and inpatient settings, enabling the company to monetize that data asset through subscription-based analytics products sold to pharmaceutical and biotech clients. The core revenue mechanics combine recurring EMR infrastructure licensing/support fees, data monetization, subscription platform services, and transaction-based distribution margins, with an enterprise field-sales motion targeting hospitals, clinics, and pharmacies and a product-led motion for newer solutions like UBIST OTC.

The company has raised approximately $72.4 million in a 2015 Series 4 led by STIC Investment plus a subsequent investment from Kakao Investment in 2018, employs 101-250 people, and maintains an active investor relations website that includes stock price information, indicating publicly traded equity. The strategic narrative centers on evolving from a single-product EMR vendor to an integrated 'Beyond EMR, Toward Medical OS' platform serving the entire Korean healthcare value chain.

Short descriptiontext

UBCare (operating as GC MediAI) provides Korea's leading medical AI platform, connecting hospitals, clinics, pharmacies, pharma firms, and patients through its #1 domestic EMR system (의사랑) and integrated data analytics, pharmaceutical distribution, and chronic disease management services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSeoul, South Korea
HQ citystring
Seoul
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical AI software, EMR systems, pharmacy management, healthcare data analytics, medical OS platform
Industry2 codes
1Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools
CodeHLACAKAHPrimaryYes
2Virtual Pharmacy & Medication Management Integration Platforms
CodeHLALABALPrimaryNo
NAICS code1 code
  • Professional, Scientific, and Technical Services54
SIC code1 code
  • Services-Health Services8000
Product category
Healthcare IT / Medical AI Software
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1EMR Infrastructure Services
TypeSubscription Recurring
Description

Revenue from providing and maintaining EMR systems (의사랑, 유팜) to hospitals, clinics, and pharmacies with subscription or licensing fees for software access and support services

gcmediai.com
2Data & Marketing Solutions
TypeData Monetisation
Description

Pharmaceutical and biotech business insights generated from prescription data (both outpatient and inpatient), sold as data analytics solutions to pharmaceutical companies

gcmediai.com
3Platform Services
TypeSubscription Recurring
Description

Patient-facing services through connected EMR platform including appointment booking and chronic disease management solutions

gcmediai.com
4Distribution & Medical Devices
TypeTransaction Fee
Description

Pharmaceutical and medical device distribution network connecting online and offline healthcare channels, providing consulting services to medical facilities

gcmediai.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

UBCare (via GC MediAI) provides Korea's leading EMR system 의사랑 and pharmacy management system 유팜, the AutoPack pharmacy automation solution, the UBIST OTC data analytics product for pharmaceutical market intelligence, and a Medical OS platform connecting hospitals, clinics, pharmacies, pharma/biotech firms, and patients. The offerings combine software infrastructure, prescription data analytics, and pharmaceutical/medical device distribution into an integrated Medical OS for the Korean healthcare ecosystem.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • #1 EMR market position in Korea
+1 more record
Product overview1 text field

GC메디아이 operates a platform-plus-modules architecture centered on Medical OS, combining medical infrastructure (의사랑 EMR and 유팜 pharmacy systems), data solutions (UBIST OTC), and a patient-facing platform for appointment booking and chronic disease management. The company connects hospitals, clinics, pharmacies, and patients through integrated medical AI technology.

Product and service1 record
1의사랑 (Euisarang) EMR
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
1아이쿱 (iCup)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-27
Description

iCup partnered with GC메디아이 and Ssure (씨어스) to expand smart bedside blood glucose management services. The partnership focuses on cooperation for spreading and expanding smart bedside blood sugar management technology in hospital settings.

gcmediai.com
2씨어스 (Ssure)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-27
Description

Ssure collaborated with iCup (아이쿱) and GC메디아이 on the 'smart bedside blood glucose management expansion cooperation' MOU. The partnership aims to promote widespread adoption of smart blood glucose monitoring at patient bedsides in medical institutions.

gcmediai.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Cloud-based EHR and healthcare IT platform with revenue-cycle and patient engagement tools; comparable in providing integrated software/data services to clinicians.

TypeEmerging player
Description

Cloud software and data platform serving life sciences and pharma; relevant comp for GC MediAI's prescription-data-driven insights sold to pharma/biotech customers.

TypeBroad incumbent
Description

Established EMR vendor serving hospitals and ambulatory networks; comparable healthcare IT infrastructure competitor across hospital segments.

TypeBroad incumbent
Description

EHR and practice management vendor serving hospitals, physician practices, and pharmacies; comparable in covering both provider and pharmacy IT workflows.

TypeBroad incumbent
Description

Global leader in healthcare data, analytics, and clinical research services for pharmaceutical companies; directly comparable to GC MediAI's data & marketing / prescription data monetisation business.

TypeBroad incumbent
Description

Dominant US-based EMR vendor used by large academic hospitals; represents the global benchmark for EMR scale and a credible competitor if Korean hospitals look to modernise platforms.

TypeRegional player
Description

Japanese medical information and physician platform; comparable Asian healthcare IT incumbent demonstrating cross-sell of physician data into pharma marketing — a relevant Asian comp for GC MediAI's data monetisation model.

TypeBroad incumbent
Description

Global EMR and healthcare IT incumbent serving hospitals worldwide; relevant as the large-scale EMR competitor that GC MediAI positions against when talking to multi-national hospital clients and large Korean systems.

TypeRegional player
Description

Japanese provider of DPC/EHR-derived real-world healthcare data sold to pharma; offers a directly comparable business model to GC MediAI's prescription data monetisation for pharmaceutical customers, though operating in Japan rather than Korea.

TypeDirect peer
Description

Another major Korean EMR/medical IT vendor competing with GC MediAI's 의사랑 for hospital and clinic contracts in South Korea. Direct overlap in Korean healthcare IT infrastructure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UBCare

Healthcare IT / Medical AI Softwareubcare.co.kr

UBCare (operating as GC MediAI) provides Korea's leading medical AI platform, connecting hospitals, clinics, pharmacies, pharma firms, and patients through its #1 domestic EMR system (의사랑) and integrated data analytics, pharmaceutical distribution, and chronic disease management services.

What UBCare does

UBCare, operating commercially as GC MediAI (주)GC메디아이), is a South Korean medical AI and healthcare IT company founded in 1992 and headquartered in Seoul's Seongdong-gu district. The company operates a platform-plus-modules architecture branded 'Medical OS' that connects hospitals, clinics, pharmacies, pharmaceutical manufacturers, and patients through four business segments: Medical Infrastructure (its market-leading 의사랑 EMR and 유팜 pharmacy management system, plus the 오토팩 pharmacy automation solution), Data & Marketing (prescription-data analytics for pharma/biotech, including the newly launched UBIST OTC general medication market analysis solution), Platform (patient-facing appointment booking and chronic disease management connected to EMR), and Distribution & Medical Devices (an integrated online-offline pharma and device distribution network).

The underlying technology combines proprietary EMR and pharmacy management software with prescription data aggregation across both outpatient and inpatient settings, enabling the company to monetize that data asset through subscription-based analytics products sold to pharmaceutical and biotech clients. The core revenue mechanics combine recurring EMR infrastructure licensing/support fees, data monetization, subscription platform services, and transaction-based distribution margins, with an enterprise field-sales motion targeting hospitals, clinics, and pharmacies and a product-led motion for newer solutions like UBIST OTC.

The company has raised approximately $72.4 million in a 2015 Series 4 led by STIC Investment plus a subsequent investment from Kakao Investment in 2018, employs 101-250 people, and maintains an active investor relations website that includes stock price information, indicating publicly traded equity. The strategic narrative centers on evolving from a single-product EMR vendor to an integrated 'Beyond EMR, Toward Medical OS' platform serving the entire Korean healthcare value chain.

UBCare firmographics

Firmographics
Name
UBCare
Legal name
(주)GC메디아이
Website
https://ubcare.co.kr
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
101–250 employees
Short description
UBCare (operating as GC MediAI) provides Korea's leading medical AI platform, connecting hospitals, clinics, pharmacies, pharma firms, and patients through its #1 domestic EMR system (의사랑) and integrated data analytics, pharmaceutical distribution, and chronic disease management services.
Ownership category
akta.pro rank

UBCare industry classification

Industry
Product category
Healthcare IT / Medical AI Software
NAICS
Professional, Scientific, and Technical Services (54)
SIC
Services-Health Services (8000)
akta.pro primary industry
Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH)
akta.pro secondary industry
Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)

Keywords

  • Medical AI software
  • EMR systems
  • Pharmacy management
  • Healthcare data analytics
  • Medical OS platform

Where UBCare is headquartered

Location

Headquarters

HQ city
Seoul
HQ country
South Korea
HQ region
Asia

Offices1 record

Markets served

UBCare business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. EMR Infrastructure Services: Revenue from providing and maintaining EMR systems (의사랑, 유팜) to hospitals, clinics, and pharmacies with subscription or licensing fees for software access and support services
  2. Data & Marketing Solutions: Pharmaceutical and biotech business insights generated from prescription data (both outpatient and inpatient), sold as data analytics solutions to pharmaceutical companies
  3. Platform Services: Patient-facing services through connected EMR platform including appointment booking and chronic disease management solutions
  4. Distribution & Medical Devices: Pharmaceutical and medical device distribution network connecting online and offline healthcare channels, providing consulting services to medical facilities

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

UBCare product offering

Product offering

Core offering

UBCare (via GC MediAI) provides Korea's leading EMR system 의사랑 and pharmacy management system 유팜, the AutoPack pharmacy automation solution, the UBIST OTC data analytics product for pharmaceutical market intelligence, and a Medical OS platform connecting hospitals, clinics, pharmacies, pharma/biotech firms, and patients. The offerings combine software infrastructure, prescription data analytics, and pharmaceutical/medical device distribution into an integrated Medical OS for the Korean healthcare ecosystem.

Product overview

GC메디아이 operates a platform-plus-modules architecture centered on Medical OS, combining medical infrastructure (의사랑 EMR and 유팜 pharmacy systems), data solutions (UBIST OTC), and a patient-facing platform for appointment booking and chronic disease management. The company connects hospitals, clinics, pharmacies, and patients through integrated medical AI technology.

Differentiator

Problem solved

Functional benefit

Products and services

  • 의사랑 (Euisarang) EMR

Quantifiable outcome

  • #1 EMR market position in Korea
  • +1 more outcomes

Companies that use UBCare

Customer profile

Segments4 records

Ideal customer profiles3 records

UBCare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

UBCare partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor.

  • 아이쿱 (iCup)minorStrategic or Co-development Partner · 27 May 2026iCup partnered with GC메디아이 and Ssure (씨어스) to expand smart bedside blood glucose management services. The partnership focuses on cooperation for spreading and expanding smart bedside blood sugar management technology in hospital settings.
  • 씨어스 (Ssure)minorStrategic or Co-development Partner · 27 May 2026Ssure collaborated with iCup (아이쿱) and GC메디아이 on the 'smart bedside blood glucose management expansion cooperation' MOU. The partnership aims to promote widespread adoption of smart blood glucose monitoring at patient bedsides in medical institutions.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

UBCare competitors and assessment

Company assessment

Broad incumbents

  • Athenahealth: Cloud-based EHR and healthcare IT platform with revenue-cycle and patient engagement tools; comparable in providing integrated software/data services to clinicians.
  • MEDITECH: Established EMR vendor serving hospitals and ambulatory networks; comparable healthcare IT infrastructure competitor across hospital segments.
  • Veradigm (formerly Allscripts): EHR and practice management vendor serving hospitals, physician practices, and pharmacies; comparable in covering both provider and pharmacy IT workflows.
  • IQVIA: Global leader in healthcare data, analytics, and clinical research services for pharmaceutical companies; directly comparable to GC MediAI's data & marketing / prescription data monetisation business.
  • Epic Systems: Dominant US-based EMR vendor used by large academic hospitals; represents the global benchmark for EMR scale and a credible competitor if Korean hospitals look to modernise platforms.
  • Cerner / Oracle Health: Global EMR and healthcare IT incumbent serving hospitals worldwide; relevant as the large-scale EMR competitor that GC MediAI positions against when talking to multi-national hospital clients and large Korean systems.

Emerging players

  • Veeva Systems: Cloud software and data platform serving life sciences and pharma; relevant comp for GC MediAI's prescription-data-driven insights sold to pharma/biotech customers.

Regional players

  • M3 (Japan): Japanese medical information and physician platform; comparable Asian healthcare IT incumbent demonstrating cross-sell of physician data into pharma marketing — a relevant Asian comp for GC MediAI's data monetisation model.
  • Medical Data Vision (Japan): Japanese provider of DPC/EHR-derived real-world healthcare data sold to pharma; offers a directly comparable business model to GC MediAI's prescription data monetisation for pharmaceutical customers, though operating in Japan rather than Korea.

Direct peers

  • ezCaretech (이지케어텍): Another major Korean EMR/medical IT vendor competing with GC MediAI's 의사랑 for hospital and clinic contracts in South Korea. Direct overlap in Korean healthcare IT infrastructure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

UBCare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UBCare leadership team

Management profile

Number of profiles

Profiles1 record

UBCare funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UBCare M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UBCare

What does UBCare do?

UBCare (via GC MediAI) provides Korea's leading EMR system 의사랑 and pharmacy management system 유팜, the AutoPack pharmacy automation solution, the UBIST OTC data analytics product for pharmaceutical market intelligence, and a Medical OS platform connecting hospitals, clinics, pharmacies, pharma/biotech firms, and patients. The offerings combine software infrastructure, prescription data analytics, and pharmaceutical/medical device distribution into an integrated Medical OS for the Korean healthcare ecosystem.

Is UBCare a public or private company?

UBCare is a private company. It is classified as venture growth investor backed and is currently operating.

When was UBCare founded?

UBCare was founded in 1992. It employs 101 to 250 people.

Where is UBCare based?

UBCare is headquartered in Seoul, South Korea, in the Asia region.

How does UBCare make money?

Four revenue lines are on record. EMR Infrastructure Services are the primary driver. The others are data & Marketing Solutions, platform Services and distribution & Medical Devices.

Who are UBCare's main competitors?

Broad incumbents on record are Athenahealth, MEDITECH, Veradigm (formerly Allscripts), IQVIA, Epic Systems and Cerner / Oracle Health. Veeva Systems is listed as an emerging player. Regional players are M3 (Japan) and Medical Data Vision (Japan). ezCaretech (이지케어텍) is listed as a direct peer.

Does UBCare have an API?

No public API is recorded for UBCare.

What industry is UBCare in?

UBCare's product category is Healthcare IT / Medical AI Software. Its primary akta.pro industry code is HLACAKAH, Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools, with a secondary code of HLALABAL, Virtual Pharmacy & Medication Management Integration Platforms. Its NAICS code is 54 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales